Table 2.
S. No. | Compounds | Docking results |
|
---|---|---|---|
Glide score | Glide energy (Kcal/mol) | ||
1 | Hydrocortisone acetate | −5.417 | −42.515 |
2 | Docosane | Not docked | |
3 | 1-Hepten-3-ol | −2.174 | −17.726 |
4 | 2-Ethyl-1-decanol | −1.768 | −22.353 |
5 | 4,5,6,8-PTetramethoxy-2,3-dihydroindeno[1,2,3-ij]isoquinolin-9-ol | −3.739 | −35.888 |
6 | Dodecane | 1.051 | −19.325 |
7 | 2,6-Dimethylheptadecane | −0.451 | −26.551 |
8 | Tridecane | −0.118 | −21.009 |
9 | Tetradecane | 0.727 | −20.445 |
10 | SCHEMBL15979821 | −3.801 | −39.263 |
11 | 6-(4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-yl-amino)hexanoic acid trifluoroacetate | −5.401 | −31.389 |
12 | Pentadecane | 0.316 | −24.655 |
13 | 3-(4-Chlorophenyl)-5-styryl[1,2,4]oxadiazole | −3.035 | −36.153 |
14 | Benzhydrazide,3-chloro-N2-[3-(4-methoxyphenyl)-1-methyl-3- oxopropenyl- | Not docked | |
15 | Orthotolidine | −3.867 | −26.139 |
16 | Diphenylvinylphosphine | −1.51 | −22.8 |
17 | 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyloctasiloxane | −1.475 | −38.258 |
18 | Phytol | −3.155 | −31.359 |
19 | Shogaol | −3.433 | −35.929 |
20 | Phenyl glucuronide | −6.635 | −35.039 |
21 | 5-tridecylbenzene-1,3-diol | −2.029 | −31.71 |
22 | Ephedrine | −3.933 | −24.321 |
23 | Tetradecamethyl hexasiloxane | Not docked | |
24 | Triacontane | Not docked | |
25 | Dioctyl phthalate | −3.361 | −38.176 |
26 | Docosane | Not docked | |
27 | Triacontane | Not docked | |
28 | Squalene | −2.14 | −31.436 |
29 | Tetracosane | Not docked | |
30 | Cyclophosphamide (FDA-approved drug) | −4.621 | −32.158 |
Highlighted bold terms indicated that, these compounds might inhibit the HER2 protein